XML 37 R25.htm IDEA: XBRL DOCUMENT v3.24.3
Disaggregated Revenues (Tables)
 9 Months Ended
Sep. 30, 2024
Disaggregation of Revenue [Abstract]  
Schedule of Disaggregation of Revenues
The following table provides information regarding total revenues (dollars in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
(unaudited)(unaudited)
Net product sales
Qelbree$62,359 $37,081 $166,857 $93,840 
GOCOVRI35,657 32,889 93,922 87,650 
Oxtellar XR29,805 29,644 86,265 82,359 
APOKYN19,867 21,510 53,811 56,324 
Trokendi XR15,318 20,625 48,393 74,734 
Other(1)
7,296 7,255 22,053 23,008 
Total net product sales170,302 149,004 471,301 417,915 
Royalty, licensing and other revenues5,387 4,876 16,357 25,292 
Total revenues$175,689 $153,880 $487,658 $443,207 
___________________________________________
(1) Includes net product sales of MYOBLOC, XADAGO and Osmolex ER.